Study on Lurbinectedin and Doxorubicin Combination vs. Doxorubicin Alone for First-line Treatment in Metastatic Leiomyosarcoma | Clinical Trial

Study on Lurbinectedin and Doxorubicin Combination vs. Doxorubicin Alone for First-line Treatment in Metastatic Leiomyosarcoma | Clinical Trial | Right2Hope